You have 9 free searches left this month | to do more
Showing 1 - 25 of
2,387 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Recruiting
  • Dyslipoproteinemias
  • PCSK9 Inhibitor [EPC]
  • Standard lipid lowering therapy
  • Dresden, Germany
    Medizinische Klinik und Poliklinik III
2022-03-18
Mar 18, 2022
U
Completed
  • Impaired Glucose Tolerance
  • Nicotinic acid
  • +4 more
  • Sherbrooke, Quebec, Canada
    centre de recherche du CHUS
2021-11-16
Nov 16, 2021
S
Completed
  • Hypercholesterolemia
  • Alirocumab SAR236553 (REGN727)
  • +11 more
  • Sao Paulo, Brazil
  • +9 more
2020-12-02
Dec 2, 2020
S
Active, not recruiting
  • Hypercholesterolaemia
  • Alirocumab SAR236553 (REGN727)
  • +12 more
  • Boca Raton, Florida
  • +45 more
2022-01-12
Jan 12, 2022
U
Completed
  • Metabolic Syndrome
  • Hypertriglyceridemia
  • omega-3 acid ethyl esters
  • +3 more
  • Sioux Falls, South Dakota
    Sanford Clinic Clinical Research Services
2021-09-28
Sep 28, 2021
S
Completed
  • Hypercholesterolaemia
  • alirocumab SAR236553 (REGN727)
  • +6 more
  • Saint Louis, Missouri
  • +15 more
2019-08-15
Aug 15, 2019
U
Completed
  • Obesity
  • training
  • +2 more
  • Toulouse, France
    Centre d'Investigation Clinique, Purpan University Toulouse Hosp
2020-07-28
Jul 28, 2020
F
Unknown status
  • Hand-Foot Skin Reaction (HFSR)
  • Nicotinic acid +Routine care
  • Routine care
  • Hangzhou, Zhejiang, China
    First People's Hospital of Hangzhou
2020-03-31
Mar 31, 2020
U
Active, not recruiting
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Irvine, California
  • +1 more
2021-11-15
Nov 15, 2021
A
Recruiting
  • Type 2 Diabetes Mellitus
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
2021-10-27
Oct 27, 2021
M
Completed
  • Hypercholesterolemia
  • nicotinic acid/laropiprant
  • Manchester, United Kingdom
    Manchester Royal Infirmary
2020-10-26
Oct 26, 2020
U
Recruiting
  • Type 2 Diabetes
  • Cold exposure
  • Oral Nicotinic acid
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
2021-10-12
Oct 12, 2021
U
Completed
  • Mitochondrial Myopathies
  • Niacin
  • Helsinki, Finland
    University of Helsinki
2021-01-21
Jan 21, 2021
A
Recruiting
  • Skeletal Muscle
  • Deuterated nicotinamide (D4-NAM) IV infusion
  • +2 more
  • Orlando, Florida
    AdventHealth Translational Research Institute
2022-02-15
Feb 15, 2022
A
Suspended
  • Diabetes Mellitus, Type 2
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
2021-10-27
Oct 27, 2021
Q
Completed
  • Covid19
  • Lymphopenia
  • Shenyang, Liaoning, China
    General Hospital of Northern Theater Command
2021-10-29
Oct 29, 2021
M
Recruiting
  • Concussion, Mild
  • Nicotinamide Riboside
  • Matching placebo
  • Minneapolis, Minnesota
  • +1 more
2022-02-17
Feb 17, 2022
P
Not yet recruiting
  • Acute Stroke
  • Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)
  • Control
  • (no location specified)
2022-03-17
Mar 17, 2022
F
Recruiting
  • Hypertension
  • Nicotinamide mononucleotide supplied as 400mg capsule
  • Lifestyle modification
  • Guangzhou, Guangdong, China
    First Affiliated Hospital,Sun Yat-sen University
2022-01-17
Jan 17, 2022
U
Completed
  • Dyslipidemia
  • ER Niacin Oral Fat Challenge
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
2020-07-08
Jul 8, 2020
M
Completed
  • Neuralgia
  • Myalgia
  • London, Ontario, Canada
    KGK Synergize now KGK Science
2021-03-24
Mar 24, 2021
C
Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Exercise Intervention
  • Nicotinamide Riboside
  • Duarte, California
    City of Hope Medical Center
2022-02-16
Feb 16, 2022
S
Active, not recruiting
  • Healthy Volunteers
  • Nicotinamide mononucleotide (NMN-C)
  • Dijon, France
    Biomed 21
2021-12-13
Dec 13, 2021
U
Active, not recruiting
  • Dyslipidemia
  • Krill Oil
  • +4 more
  • Davis, California
    UC Davis, Ragle Human Nutrition Center
2021-08-09
Aug 9, 2021